ad

Sudeep Pharma IPO Listing Preview: What to Expect Now?

26 Nov 20252:48 pm

Sudeep Pharma IPO Listing Preview: What to Expect Now?

Sudeep Pharma IPO Listing: The Sudeep Pharma Limited listing is to be made on 28th November 2025. The IPO was opened for bidding from 21st November 2025 to 25th November 2025. It is a bookbuilding IPO of ₹895 crores, comprising a fresh issue of 16,00,000 shares and the offer for sale of 1.35 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 28th November 2025. Scroll down to know more about Sudeep Pharma IPO listing expectations.

Sudeep Pharma IPO Listing Preview

As per the recent updates, the Sudeep Pharma IPO listing could be made at around

₹690 per share on 28th November 2025. This conclusion is made based on Sudeep Pharma GMP (grey market premium). However, the GMP and expected listing price are subject to change based on market sentiment. Stay informed with Univest to get live updates on the Complex Cinemas IPO listing or GMP trends. Scroll to explore the GMP of the Sudeep Pharma IPO.

Sudeep Pharma IPO GMP Grey Market Premium

GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Sudeep Pharma IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

GMP DateIPO PriceGMPEstimated Listing Price Estimated Listing Gains
26-11-2025₹593.00₹97.00₹690.0016.36%
25-11-2025₹593.00₹86.00₹679.0014.50%
24-11-2025₹593.00₹90.00₹683.0015.18%
23-11-2025₹593.00₹121.00₹714.0020.40%
22-11-2025₹593.00₹121.00₹714.0020.40%
21-11-2025₹593.00₹111.00₹704.0018.72%
20-11-2025₹593.00₹122.00₹715.0020.57%
19-11-2025₹593.00₹130.00₹723.0021.92%
18-11-2025₹593.00₹93.00₹686.0015.68%
17-11-2025₹593.00₹0.00₹686.000.00%

As of 26th November 2025, the Sudeep Pharma IPO GMP stands at ₹97 per share. This means shares are likely to list at ₹690 on their tentative listing date, 28th November 2025.

GMP data is subject to change based on market conditions. You should check the live GMP status before applying for the Sudeep Pharma IPO GMP. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends.

Sudeep Pharma GMP Financials

The company’s financial analysis is essential before applying for Sudeep Pharma Limited’s IPO. Refer to the table to learn about Sudeep Pharma Limited’s financial information. 

Year Ended30th June 202531st March 2025 (in cr.)31st March 2024 (in cr.)31st March 2023 (in cr.)
Assets922.26717.17513.87420.11
Revenue130.08511.33465.38438.26
Profit After Tax31.27138.69133.1562.32
EBITDA48.57199.28187.7698.64
Net Worth688.32497.53359.07226.29
Reserve and Surplus668.52481.11354.59221.88
Total Borrowing135.97135.2575.0382.26

Explanation

Sudeep Pharma Limited’s revenue increased by 10% from ₹465.38 crore in March 2024 to ₹511.33 crore in March 2025. Moreover, the company’s PAT increased by 4% from ₹133.15 crores to ₹138.69 crores. Investors can analyse other relevant factors and make a decision accordingly.

How to Check Sudeep Pharma IPO Allotment Status?

Sudeep Pharma IPO Allotment

You can check for the Sudeep Pharma IPO allotment in different ways. These include NSE and the registrar portal. Follow the steps below to check your allotment status online.

Check On NSE

  • Visit the NSE Official Website.
  • Navigate to the IPO Allotment Section. 
  • Select Equity as the issue type. 
  • Choose the Sudeep Pharma IPO.  
  • Choose whether to proceed with the PAN number or the application number.
  • Submit your details to get the allotment status online. 

Check On the Registrar Portal

  • Visit the registrar portal. 
  • Click on the allotment option.
  • Fill in the required details.
  • Click on the submit button to know your Sudeep Pharma IPO allotment status.

Recent Articles

HBL Engineering Q1 Results FY26: Q1 PAT Rises 78.87% to ₹143.27 Crore; Revenue Up 15.70% YoY

Fine Organic Q1 Results FY26: Q1 PAT Rose 7.04% to ₹117.10 Crore; Revenue Up 7.04% YoY

Eureka Forbes Q1 Results FY26: Q1 PAT Rises 20.32% to ₹38.68 Crore; Revenue Up 9.85% YoY

JM Financial Q1 Results FY26: Q1 PAT Rose 165.85% to ₹453.81 Crore; Revenue Up 3.18% YoY

IPCA Laboratories Q1 Results FY26: Q1 PAT Rises 21.31% to ₹233.21 Crore; Revenue Up 10.33% YoY

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
Google for Startups Accelerator 2024
Trusted by 70 lakh+ Indians
Awarded No. 1 by Economic times